Neurology and Neurorehabilitation
Clinique Valmont, Switzerland
Julien Bogousslavsky (born 1954) graduated in 1978 from the University of Geneva, before training in neurology in Paris, Zurich, London Ontario, and Lausanne. His main fields of expertise in neurology and neuro-rehabilitation include cerebrovascular disease and stroke (acute therapy, prevention, and recovery), neurodegenerative diseases and movement disorders, multiple sclerosis, higher brain function disorders and Alzheimer’s disease, and general neurology. He founded the Lausanne Stroke Registry, which has included over 5,000 patients with first stroke, and made several princeps reports on brain functions and their disorders, and on behavioural neurology (the extended-self syndrome, hyperacute aphasia, creativity after brain damage, fatigue from focal brain lesion). In stroke, his studies have covered treatment, prevention, epidemiology, heart disease, lacunar stroke, emotional disorders, post-stroke depression, neuro-imaging, borderzone ischemia and other stroke subtypes. He has contributed as chair, executive or steering committee member, or safety and data management committee member in numerous multicenter randomized clinical trials for acute stroke therapy and stroke prevention, and has evaluated, among others, thrombolytic therapies, antiplatelet agents, statins, and various neuroprotective agents. His present research is now mainly focused on the study of neurological disorders affecting artistic creativity and in projects on the history of neurology and psychiatry. From 1996 to 2006, he was Professor and Chairman of the Department of Neurology, Professor of Cerebrovascular Disease at the University of Lausanne, and Head of Neurology Services at University Hospital, Lausanne, Switzerland. Since 2006, he has been Chief of Neurology and Neurorehabilitation Services at the Valmont Hospital (Glion/Montreux), and medical head of the Center for Brain and Nervous System Diseases (Neurocentre) in the Genolier Swiss Medical Network, which presently covers 12 leading hospitals in Switzerland. Since 2007, he occupies an invited professorship at the University of Franche-Comté (France) for the master in neurosciences. He is author or co-author of over 600 articles published in peer-reviewed journals, and author or editor of over 50 books. He has given over 120 guest and named lectures in all continents, including the 2002 Feinberg award lecture of the American Heart Association. He was founding chief editor of the journal “Cerebrovascular Diseases”, and co-founder of the European Stroke Conference, before chairing the European Stroke Council during the term 1998-2000. He was elected president of the International Stroke Society in 2004. He has been a member of the executive committee of the European Neurological Society (1997-2001), and was elected (2001) and re-elected (2004) one of the three Trustees of the Executive Board of the World Federation of Neurology (WFN) (in 2005, he won the election for Secretary-General of WFN but did not take office). He has also acted as expert for several organizations, including the Food and Drug Administration, the European Community, the British Medical Research Council, and other national research councils. He is currently editor-in-chief of 3 journals: “European Neurology”, the third oldest scientific journal in the field, founded by Carl Wernicke, of “Frontiers in Neurology and Neuroscience”, and of “Case Reports in Neurology”, with present and past appointments on the editorial boards of several international journals.
Stroke and cerebrovascular disease, including acute stroke therapy, stroke prevention and rehabilitation, clinical trials, neuro-imaging, and clinical syndromes. Behavioral neurology and neuropsychiatry. Eye movement disorders. Recovery after focal CNS injury, creativity after brain lesion.